| Zum Hauptmenu. | Zum Bereichsmenu. | Zur Metanavigation. | Zur Suche. | Direkt zum Inhalt.
Wacker Chemie AG will discontinue the production of its PIOLOFORM® polymer binders effective September 30, 2008.
Pieris AG, a biopharmaceutical company developing Anticalins®, a novel class of targeted human protein therapeutics, and Wacker Biotech GmbH, a full-service contract manufacturer of biopharmaceuticals, announced today a significant milestone in the development of Pieris’ PRS-050 Anticalin® for clinical trials.
Today, Wacker Chemie AG held a topping-out ceremony for its biotech segment’s new lab building in Jena.
WACKER, the Munich-based chemical group, has succeeded in developing UV-active silicone elastomers with a significantly enhanced property profile.
WACKER, the Munich-based chemical company, is raising its prices for silicone products worldwide effective October 1, 2008.